Drug class
Selective sphingosine 1-phosphate (S1P) receptor modulator; immunomodulatory agent
Mechanism of action
Binds S1P receptor subtypes 1, 4 and 5, with functional antagonism at S1P1 that reduces lymphocyte egress from lymph nodes and circulating lymphocyte counts, limiting lymphocyte migration to inflamed intestinal tissue.
General use cases
- Treatment of moderately to severely active ulcerative colitis in adults who have had an inadequate response, loss of response or intolerance to conventional therapy or a biologic agent, under the applicable product label
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
